Disclosure Statement

It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty and activity planners involved in the development of this activity have disclosed any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a faculty member with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation has identified and resolved any and all faculty conflicts of interest prior to the release of this activity.

Faculty Disclosures

Joseph A. Caprini, MD, MS, FACS, has served as a consultant for Bayer, Conva Tec, Covidien, Eisai, GlaxoSmithKline, and sanofi-aventis.

Steven Deitelzweig, MD, FACP, has received grant/research support from Bayer and Pfizer. He has served as a consultant for Bristol-Myers Squibb, GlaxoSmithKline, Merck, Pfizer, and sanofi-aventis.

Franklin A. Michota Jr, MD, has served as a consultant for Genentech, Osaka Pharmaceutical, and sanofi-aventis.

The France Foundation Staff: The staff involved with this activity have reported no relevant financial relationships with commercial interests.